| Drug Name: | Natalizumab (189261-10-7) |
|---|---|
| PubChem ID: | 124081182 |
| SMILES: | CCCCC[C@@H](C)CCC[C@@H](C)CCC/C(=C/COC(=O)CC[C@H]1[C@@H](/C/2=C/C3=C(C(=C([N-]3)/C=C4/[C@@H]([C@H](/C(=C/C5=C(C6=C([N-]5)/C(=C1[N-]2)/[C@H](C6=O)C(=O)OC)C)/[N-]4)CC)C)C(=O)C)C)C)/C.[Mg+2] |
| InchiKey: | LLSYGMXWVHQLAE-CXYCEOACSA-L |
| Therapeutic Category: | Immunologic Factors |
| Molecular Weight (dalton) | : | 897.497 |
| LogP | : | 11.79854 |
| Ring Count | : | 3 |
| Hydrogen Bond Acceptor Count | : | 6 |
| Hydrogen Bond Donor Count | : | 0 |
| Total Polar Surface Area | : | 143.14 |
This panel provides information on interacting drugs and their ADRs along with references
| Interacting drug | Toxicity | Interaction Type | Mechanism | Reference |
|---|
This panel provides drug-protein interaction and their ADRs along with references
| Toxicity | Interacting Protein | Mechanism | Reference |
|---|
This panel provides drug-food interactions and their ADRs along with references
| Food | Toxicity | Reference |
|---|
This panel provides information on metabolites and their ADRs along with references
| Metabolite | Toxicity | Place of Metabolism | Mechanism | Reference |
|---|
This panel provides information on drug category